Jazz Pharmaceuticals PLC (JAZZ)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	726,630	738,084	650,266	608,459	658,307	567,697	553,716	481,626	443,120	380,886	250,844	95,708	170,278	294,312	462,150	729,866	378,073	265,904	202,800	208,957
Revenue (ttm)	US$ in thousands	4,068,943	3,992,713	3,909,883	3,843,380	3,834,209	3,794,392	3,762,904	3,738,465	3,659,374	3,583,982	3,481,445	3,300,378	3,094,238	2,863,024	2,625,797	2,436,422	2,363,567	2,279,790	2,216,604	2,188,301
Operating profit margin		17.86%	18.49%	16.63%	15.83%	17.17%	14.96%	14.72%	12.88%	12.11%	10.63%	7.21%	2.90%	5.50%	10.28%	17.60%	29.96%	16.00%	11.66%	9.15%	9.55%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $726,630K ÷ $4,068,943K
= 17.86%

The operating profit margin of Jazz Pharmaceuticals PLC has shown fluctuation over the period analyzed. Starting at 9.55% in March 2020, the margin decreased slightly to 9.15% by June 2020. However, there was a notable improvement in profitability with the margin rising to 16.00% by December 2020.

The trend continued to strengthen in the following quarters, reaching a peak of 29.96% in March 2021, indicating a significant increase in operational efficiency and profitability. Subsequently, the margin experienced a slight decline before stabilizing around 15-18% from June 2024 to December 2024.

Overall, Jazz Pharmaceuticals PLC has demonstrated varying levels of operating profitability, with notable improvements in certain periods but also experiencing fluctuations. This indicates the company's ability to manage its operating costs effectively and generate profit from its core business activities.